Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Ropivacaine for TAP Block in Laparoscopic Cholecystectomy
NCT07577934Recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- May 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Tianjin First Central Hospital. Primary endpoint: Postoperative dynamic Numeric Rating Scale pain score at 24 hours. Started May 2026; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07577934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07577934.